Ignite Creation Date:
2024-05-06 @ 8:37 AM
Last Modification Date:
2024-10-26 @ 12:03 PM
Study NCT ID:
NCT02786381
Status:
COMPLETED
Last Update Posted:
2016-11-22
First Post:
2015-12-04
Brief Title:
Idylla IFV-RSV Panel Clinical Testing
Sponsor:
Organization:
Janssen Pharmaceutica NV Belgium
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
Nasal swabs NS Nasopharyngeal swabs NP in viral transport medium VTM
Enrollment Count:
213
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Time Perspective List:
Who Masked List: